120 related articles for article (PubMed ID: 17237557)
1. Prioritizing primary care in HIV: comorbidity, toxicity, and demography.
Justice AC
Top HIV Med; 2006 Dec-2007 Jan; 14(5):159-63. PubMed ID: 17237557
[TBL] [Abstract][Full Text] [Related]
2. Medical interventions for addictions in the primary care setting.
Bruce RD
Top HIV Med; 2010; 18(1):8-12. PubMed ID: 20305310
[TBL] [Abstract][Full Text] [Related]
3. Optimizing treatment outcomes in HIV-infected patients with substance abuse issues.
Celentano DD; Lucas G
Clin Infect Dis; 2007 Dec; 45 Suppl 4():S318-23. PubMed ID: 18190306
[TBL] [Abstract][Full Text] [Related]
4. Triple diagnosis: dual diagnosis and HIV disease, Part 1.
Douaihy AB; Jou RJ; Gorske T; Salloum IM
AIDS Read; 2003 Jul; 13(7):331-2, 339-41. PubMed ID: 12889451
[TBL] [Abstract][Full Text] [Related]
5. Behavioral aspects of HIV care: adherence, depression, substance use, and HIV-transmission behaviors.
Berg CJ; Michelson SE; Safren SA
Infect Dis Clin North Am; 2007 Mar; 21(1):181-200, x. PubMed ID: 17502235
[TBL] [Abstract][Full Text] [Related]
6. Update on cardiovascular complications in HIV infection.
Currier JS
Top HIV Med; 2009; 17(3):98-103. PubMed ID: 19675367
[TBL] [Abstract][Full Text] [Related]
7. HIV testing: rationale for changing recommendations.
Janssen RS
Top HIV Med; 2007; 15(1):6-10. PubMed ID: 17406078
[TBL] [Abstract][Full Text] [Related]
8. End-stage liver disease in HIV disease.
Peters MG
Top HIV Med; 2009; 17(4):124-8. PubMed ID: 19890184
[TBL] [Abstract][Full Text] [Related]
9. Immunizations for HIV-infected adults: indications, timing, and response.
Spach DH
Top HIV Med; 2006 Dec-2007 Jan; 14(5):154-8. PubMed ID: 17237556
[TBL] [Abstract][Full Text] [Related]
10. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
11. Impact of drug abuse treatment modalities on adherence to ART/HAART among a cohort of HIV seropositive women.
Kapadia F; Vlahov D; Wu Y; Cohen MH; Greenblatt RM; Howard AA; Cook JA; Goparaju L; Golub E; Richardson J; Wilson TE
Am J Drug Alcohol Abuse; 2008; 34(2):161-70. PubMed ID: 18293232
[TBL] [Abstract][Full Text] [Related]
12. Survival of HIV-infected injection drug users (IDUs) in the highly active antiretroviral therapy era, relative to sex- and age-specific survival of HIV-uninfected IDUs.
Muga R; Langohr K; Tor J; Sanvisens A; Serra I; Rey-Joly C; Muñoz A
Clin Infect Dis; 2007 Aug; 45(3):370-6. PubMed ID: 17599317
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data.
Protopopescu C; Raffi F; Roux P; Reynes J; Dellamonica P; Spire B; Leport C; Carrieri MP;
J Antimicrob Chemother; 2009 Sep; 64(3):599-606. PubMed ID: 19602563
[TBL] [Abstract][Full Text] [Related]
15. Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST).
Spire B; Lucas GM; Carrieri MP
Int J Drug Policy; 2007 Aug; 18(4):262-70. PubMed ID: 17689374
[TBL] [Abstract][Full Text] [Related]
16. Improved survival in HIV-infected persons: consequences and perspectives.
Lohse N; Hansen AB; Gerstoft J; Obel N
J Antimicrob Chemother; 2007 Sep; 60(3):461-3. PubMed ID: 17609196
[TBL] [Abstract][Full Text] [Related]
17. Renal dysfunction and tenofovir toxicity in HIV-infected patients.
Szczech LA
Top HIV Med; 2008; 16(4):122-6. PubMed ID: 18838746
[TBL] [Abstract][Full Text] [Related]
18. Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa.
Reddi A; Leeper SC; Grobler AC; Geddes R; France KH; Dorse GL; Vlok WJ; Mntambo M; Thomas M; Nixon K; Holst HL; Karim QA; Rollins NC; Coovadia HM; Giddy J
BMC Pediatr; 2007 Mar; 7():13. PubMed ID: 17367540
[TBL] [Abstract][Full Text] [Related]
19. Critical care of HIV infected patients in the highly active antiretroviral therapy era.
Corona A; Raimondi F
Minerva Anestesiol; 2007 Dec; 73(12):635-45. PubMed ID: 18046294
[TBL] [Abstract][Full Text] [Related]
20. Substance abuse and HIV infection.
Francis H
Top HIV Med; 2003; 11(1):20-4. PubMed ID: 12717047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
